Melanoma and Cutaneous Malignancy Tumor Board 2023-2024 - 12/13/2023

---

RSSAAPAABSCCMOCCMECNEMOCSafety

Wednesday, December 13, 2023, 12:00 PM - 1:00 PM, PCAM South Tower Room 10-124

Melanoma and Cutaneous Malignancy Tumor Board is designed to give healthcare professionals the opportunity to collaborate on the care of patients who have been diagnosed with melanoma, skin cancer, or other skin malignancy/risk factors. Providers submit their most complex cases in order to seek insight on the best patient care via the collaboration of clinicians such as surgeons, oncologists, radiologists, pathologists, physician assistants, nurse practitioners, and registered nurses.

Objective(s):
Location: PCAM South Tower Room 10-124
Specialties: DERMATOLOGY, INTERNAL MEDICINE - Medical Oncology, PATHOLOGY - CLINICAL, RADIATION ONCOLOGY, OTOLARYNGOLOGY, DERMATOLOGY - Dermatopathology, PATHOLOGY - ANATOMIC, OBSTETRICS AND GYNECOLOGY - Gynecologic Oncology, PATHOLOGY - Dermatopathology, INTERNAL MEDICINE - Hospice and Palliative Medicine, SURGERY - Complex General Surgical Oncology

Faculty Disclosures:
Lynn M Schuchter, MD (Nothing to disclose - 09/12/2023)
Download Handout

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Designation of Credit
Physicians: Penn Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1 Credits™ (1.00 hours), ABIM MOC Part 2 (1.00 hours), ABPath MOC Part II (1.00 hours), ABS CC (1.00 hours), American Academy of Physician Assistants (1.00 hours), NCPD Hours (ANCC) (1.00 hours), Non-Physician Attendance / Participation (1.00 hours), Patient Safety/Risk Management PSRM (1.00 hours)

Mitigation of Relevant Financial Relationships

Penn Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Date	Empty Column	Title
		No activities are currently published for this month.
No upcoming dates have been setup.